TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
SPRO

Spero Therapeutics Inc

Healthcare · Biotechnology

1.20$ -1.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Spero Therapeutics Inc (SPRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 69 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SPRO
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
7.2 14 93 129 106 153 171 125 182 111 69
6.0 12 87 115 95 139 158 109 131 107 67
5.7 10 87 34 30 85 113 109 76 53 40
5.7 10 87 115 82 127 146 109 76 53 40
0.0 0.3 2.9 1.3 10 6.2 2.6 1.1 51 52 25
– – -4.8 -8.8 -13 -12 -0.4 -4.5 0.0 – –
0.9 1.5 1.2 2.9 7.1 1.7 7.6 5.5 – – –
– – 0.0 – – – – – – – –
– – 0.0 – – – – – – – –
7.4 7.4 8.5 13 32 21 83 49 75 64 9.9
6.4 6.9 8.2 12 27 14 19 22 37 49 8.9
0.7 – 0.2 0.2 0.9 0.9 1.4 1.7 1.7 1.7 2.0
1.8 1.1 3.5 3.6 4.1 1.2 1.1 0.6 1.4 7.3 0.7
– – 0.0 – 0.2 0.2 – – – – –
0.2 10 85 116 75 132 88 76 107 46 59
-18 -45 -97 -139 -199 -278 -367 -414 -391 -460 -451
6.6 6.6 2.6 16 18 22 31 38 53 54 59

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?